drugset / Trial / NCT01872715

Patient Centered Outcomes in Rosacea: An Exploratory Multi-media Analysis of the Patient Experience on Oracea

NCT01872715

Phase 4 Completed 24 enrolled Galderma R&D
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to characterize rosacea patients', being treated with Oracea, perception through visual analog scale reporting.

Timeline

Start
2013-03
Primary completion
2013-06
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Doxycycline Small molecule 40 mg Oral

Indications